Galectin Therapeutics (GALT) Gains Again on Takeover, NASH Trial Speculation Sep 21, 2016 10:53AM
Galectin Therapeutics (GALT) May Have Best Read-Through From Allergan's Tobira (TBRA) Deal - H.C. Wainwright's Arce Sep 20, 2016 01:09PM